Evidence of momentum dependent hybridization in Ce2Co0.8Si3.2

We studied the electronic structure of the Kondo lattice system Ce2Co0.8Si3.2 by angle-resolved photoemission spectroscopy (ARPES). The spectra obtained below the coherence temperature consist of a Kondo resonance, its spin-orbit partner and a number of dispersing bands. The quasiparticle weight related to the Kondo peak depends strongly on Fermi vectors associated with bulk bands. This indicates a highly anisotropic hybridization between conduction band and 4f electrons - V_{cf} in Ce2Co0.8Si3.2.Comment: 6 page

Generalized Spectral Signatures of Electron Fractionalization in Quasi-One and -Two Dimensional Molybdenum Bronzes and Superconducting Cuprates

We establish the quasi-one-dimensional Li purple bronze as a photoemission paradigm of Luttinger liquid behavior. We also show that generalized signatures of electron fractionalization are present in the angle resolved photoemission spectra for quasi-two-dimensional purple bronzes and certain cuprates. An important component of our analysis for the quasi-two-dimensional systems is the proposal of a ``melted holon'' scenario for the k-independent background that accompanies but does not interact with the peaks that disperse to define the Fermi surface.Comment: 7 pages, 8 figure

Fully Gapped Single-Particle Excitations in the Lightly Doped Cuprates

The low-energy excitations of the lightly doped cuprates were studied by angle-resolved photoemission spectroscopy. A finite gap was measured over the entire Brillouin zone, including along the d_{x^2 - y^2} nodal line. This effect was observed to be generic to the normal states of numerous cuprates, including hole-doped La_{2-x}Sr_{x}CuO_{4} and Ca_{2-x}Na_{x}CuO_{2}Cl_{2} and electron-doped Nd_{2-x}Ce_{x}CuO_{4}. In all compounds, the gap appears to close with increasing carrier doping. We consider various scenarios to explain our results, including the possible effects of chemical disorder, electronic inhomogeneity, and a competing phase.Comment: To appear in Phys. Rev.

Effects of articaine on [3H]noradrenaline release from cortical and spinal cord slices prepared from normal and streptozotocin-induced diabetic rats and compared to lidocaine.

Since a significant proportion of diabetic patients have clinical or subclinical neuropathy, there may be concerns about the use of local anaesthetics. The present study was designed to determine and compare the effects of articaine, a widely used anaesthetic in dental practice, and lidocaine on the resting and axonal stimulation-evoked release of [3H]noradrenaline ([3H]NA) in prefrontal cortex slices and the release of [3H]NA in spinal cord slices prepared from non-diabetic and streptozocin (STZ)-induced diabetic (glucose level=22.03+/-2.31mmol/l) rats. The peak of allodynia was achieved 9 weeks after STZ-treatment. Articaine and lidocaine inhibited the stimulation-evoked release in a concentration-dependent manner and increased the resting release by two to six times. These effects indicate an inhibitory action of these anaesthetics on Na+- and K+-channels. There was no difference in clinically important nerve conduction between non-diabetic and diabetic rats, as measured by the release of transmitter in response to axonal stimulation. The uptake and resting release of NA was significantly higher in the brain slices prepared from diabetic rats, but there were no differences in the spinal cord. For the adverse effects, the effects of articaine on K+ channels (resting release) are more pronounced compared to lidocaine. In this respect, articaine has a thiophene ring with high lipid solubility, which may present potential risks for some patients

FTIR spectroscopy of water glass - the binder moulding modified by ZnO nanoparticles

The subject of the paper is the determination of the infl uence of the colloidal nanoparticles of zinc oxide on the structure of sodium water glass. Nanoparticles of zinc oxide in ethanol solvent were introduced into the water glass. The modification and structural changes were determined by means of the FT-IR absorption spectra. In order to determine the kind of infl uence: binder-modifier the spectroscopic FTIR analysis of samples of a fresh binder and of a binder hardened for 24 h in the air was performed by means of the spectrometer Digilab Excalibur with a standard DTGS detector

Modulation of the endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans

Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognitive flexibility) in healthy subjects. One hundred and fifty seven subjects were included and assessed with the Wisconsin Card Sorting Test; Stroop Color and Word Test; and Iowa Gambling Task. All participants were female, aged between 18 and 60 years and spoke Spanish as their first language. Results showed a negative correlation between 2-AG and cognitive flexibility performance (r = −.37; p<.05). A positive correlation was found between AEA concentrations and both cognitive flexibility (r = .59; p<.05) and decision making performance (r = .23; P<.05). There was no significant correlation between either 2-AG (r = −.17) or AEA (r = −.08) concentrations and inhibition response. These results show, in humans, a relevant modulation of the endocannabinoid system on prefrontal-dependent cognitive functioning. The present study might have significant implications for the underlying executive alterations described in some psychiatric disorders currently associated with endocannabinoids deregulation (namely drug abuse/dependence, depression, obesity and eating disorders). Understanding the neurobiology of their dysexecutive profile might certainly contribute to the development of new treatments and pharmacological approaches